Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work

Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work Survey

This study investigates the usefulness of the Self Care at Work Handbook in order to generate an improved version. Information from this study may help researchers identify potential factors associated with perception and usefulness of the Self Care at Work Handbook.

Study Overview

• Status: Withdrawn
• Conditions: Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
• Intervention / Treatment: Other: Survey Administration

Detailed Description

PRIMARY OBJECTIVES:

I. To explore the global perception of the perceived usefulness of the handbook, and the frequency that the handbook is consulted.

II. To explore the perceived usefulness of and adherence to each individual item of the handbook.

III. To solicit personnel for their ideas about the handbook, and particularly any additional handbook items they might suggest.

IV. To explore any relationships between the actual use or the perceived importance of each handbook item with respondents' self-reported professional satisfaction.

V. To explore any associations between responses to handbook items and professional, demographic, and work satisfaction characteristics before and during the coronavirus disease 2019 (COVID-19) crisis.

VI. To explore respondents' global perceptions of the usefulness and adherence to the handbook before and during the COVID-19 crisis.

OUTLINE:

Participants complete a survey over 20 minutes.

• Study Type: Observational

Contacts and Locations

Study Locations

• United States
  • Texas
    • Houston, Texas, United States, 77030
      • M D Anderson Cancer Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Clinicians in the Department of Palliative, Rehabilitation, and Integrative Medicine at M D Anderson Cancer Center

Description

Inclusion Criteria:

• Clinicians in the Department of Palliative, Rehabilitation, and Integrative Medicine. This includes physicians, advanced practice providers (APPs), and other clinical staff in the Supportive Care Center and Acute Palliative Care Unit

Exclusion Criteria:

No

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Observational (survey); Participants complete a survey over 20 minutes.	Other: Survey Administration; Complete survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Global perception of usefulness	Will be assessed by survey question E, which has five options: very useful, useful, neither useful nor useless, useless and very useless. The main interest is the proportion of responders who select very useful and useful.	through study completion, an average of 1 year
Frequency of consultation	Will be assessed by survey question D, which has five options: never, once a month or less, a few times a month, a few times a week and daily. The main interest is the proportion of responders who select daily and a few times a week.	through study completion, an average of 1 year
Perceived usefulness of individual items	Will be assessed by survey question F 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis.	through study completion, an average of 1 year
Adherence to individual items	Will be assessed by survey question G 1-9. Frequency and proportion will be used to summarize each item. For responders who select neither useful nor useless, useless and very useless, additional questions about whether one item should be retained, discarded or modified will be summarized using frequency and proportion. Comments or suggestions will be collected for qualitative analysis.	through study completion, an average of 1 year
Personal ideas about the handbook	Will be collected by survey question I and question J. Comments and suggestions will be collected and used to aggregate opinions toward handbook improvement.	through study completion, an average of 1 year
Responders' self-reported professional satisfaction	Will be assessed by survey question K, L1, and L3. Association between the perceived usefulness and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and professional satisfaction will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate.	through study completion, an average of 1 year
Responders' profession	Will be summarized by survey question A, and responders' demographics will be summarized by survey question B and C. Responders' work satisfaction after coronavirus disease 2019 (COVID-19) will be examined by survey question L2 and L4. Association between the perceived usefulness and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate. Association between the adherence and responders' profession/demographics/work satisfaction after COVID-19 will be evaluated by Chi-squared test or Fisher's exact test whichever appropriate.	through study completion, an average of 1 year
Responders' global perceptions of usefulness and adherence to the handbook during COVID-19	Will be assessed by survey question M, N and O, and frequency and proportion will be used to summarize the results.	through study completion, an average of 1 year

Collaborators and Investigators

• Sponsor: M.D. Anderson Cancer Center

Publications and helpful links

Helpful Links

• MD Anderson Cancer Center

Study record dates

Study Major Dates

• Study Start (Actual): December 3, 2020
• Primary Completion (Actual): March 30, 2023
• Study Completion (Actual): March 30, 2023

Study Registration Dates

• First Submitted: August 24, 2021
• First Submitted That Met QC Criteria: August 31, 2021
• First Posted (Actual): September 9, 2021

Study Record Updates

• Last Update Posted (Actual): March 31, 2023
• Last Update Submitted That Met QC Criteria: March 30, 2023
• Last Verified: March 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Neoplasms
• Other Study ID Numbers: 2020-0792 (M D Anderson Cancer Center); NCI-2021-08920 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No